Page last updated: 2024-10-28

hydrochlorothiazide and Neoplasms, Squamous Cell

hydrochlorothiazide has been researched along with Neoplasms, Squamous Cell in 2 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Neoplasms, Squamous Cell: Neoplasms of the SQUAMOUS EPITHELIAL CELLS. The concept does not refer to neoplasms located in tissue composed of squamous elements.

Research Excerpts

ExcerptRelevanceReference
"Non-melanoma skin cancer is the most prevalent malignancy in fair-skinned people and its incidence is increasing."2.66Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature. ( Borges-Costa, J; Garrido, PM, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Garrido, PM1
Borges-Costa, J1
El-Haddad, B1
Hammoud, D1
Shaver, T1
Shahouri, S1

Reviews

1 review available for hydrochlorothiazide and Neoplasms, Squamous Cell

ArticleYear
Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature.
    Revista portuguesa de cardiologia, 2020, Volume: 39, Issue:3

    Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Carcinoma, Basal Cell; Humans; Hydrochlorothiazide

2020

Other Studies

1 other study available for hydrochlorothiazide and Neoplasms, Squamous Cell

ArticleYear
Malignancy-associated multicentric reticulohistiocytosis.
    Rheumatology international, 2011, Volume: 31, Issue:9

    Topics: Antihypertensive Agents; Antineoplastic Agents; Arthralgia; Atenolol; Combined Modality Therapy; Dru

2011